- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 231/56 - BenzopyrazolesHydrogenated benzopyrazoles
Patent holdings for IPC class C07D 231/56
Total number of patents in this class: 1767
10-year publication summary
|
123
|
138
|
141
|
119
|
119
|
100
|
115
|
115
|
101
|
57
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme LLC | 3734 |
34 |
| Nerviano Medical Sciences S.r.l. | 237 |
27 |
| Takeda Pharmaceutical Company Limited | 2712 |
26 |
| Bristol-myers Squibb Company | 4742 |
23 |
| F. Hoffmann-La Roche AG | 7837 |
21 |
| Merck Sharp & Dohme Corp. | 2183 |
21 |
| Janssen Pharmaceutica N.V. | 3168 |
21 |
| Glaxo Group Limited | 4375 |
20 |
| LG Chem, Ltd. | 17921 |
20 |
| Array BioPharma Inc. | 446 |
20 |
| Abbvie Inc. | 1836 |
19 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 873 |
19 |
| Bayer Pharma AG | 1014 |
17 |
| Boehringer Ingelheim International GmbH | 4493 |
15 |
| The Regents of the University of California | 20745 |
14 |
| AstraZeneca AB | 2814 |
14 |
| Pfizer Inc. | 3386 |
14 |
| Merck Patent GmbH | 5728 |
14 |
| Genentech, Inc. | 4104 |
12 |
| BioAge Labs, Inc. | 45 |
12 |
| Other owners | 1384 |